Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BPMC's hCG patent challenged by Kaiser; BPMC seeking royalties of $3-$9 per prenatal test.

This article was originally published in The Gray Sheet

Executive Summary

BPMC'S hCG PATENT CHALLENGED BY KAISER PERMANENTE complaint filed in the U.S. District Court for northern California on Aug. 28. Kaiser maintains that a patent received by Biomedical Patent Management Corp. principal Mark Bogart is not infringed by the "triple marker" test widely used for diagnosis of birth defects in pregnant women, according to the six-page suit. Bogart's patent, #4,874,693, was issued in 1989.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008705

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel